Look, for a start these are not even pharma companies. You're acting like a smart *** but don't even understand the basics.Okay last response here cause it's very clear you don't understand the pharmaceutical industry or the science behind at all. Mouse models are literally the basis for basically all biotech/health care development. Models are constructed for basically every condition known to man on mice to test their ability to translate into humans, and billions of dollars a year are invested on the basis of these models. From there, they apply the treatment to human cells in vivo to show the ability to translate to humans.
This study is no different. If the science is legitimate and the models are suitable through the peer review process they will get an investor quite quickly.
Last edited: